Why Novavax's Stock Is Trading Higher Today

Novavax NVAX shares are trading higher on Friday after Cantor Fitzgerald raised its price target on the stock from $45 to $88.

The stock has regained investor interest amid a resurgence in coronavirus cases, as the company is working on a vaccine candidate.

Novavax is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases.

Novavax shares were trading up 6.55% at $63.15 at time of publication on Friday. The stock has a 52-week high of $64.32 and a 52-week low of $3.54.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Price TargetAnalyst Ratingswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!